General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Alnylam(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Alexion(MODEST), AstraZeneca Pharmaceuticals(MODEST), BridgeBio(MODEST), Pfizer Inc(SIGNIFICANT)

View Full Disclosure